The increased levels of IL-18R we observed on the TCR Vβ21.3+ T cells and CD16+ NK cells of MIS-C patients suggested activation of this pathway29. The gene discussed is FCGR3A; the disease is COVID-19–associated multisystem inflammatory syndrome in children.